Back to News
Market Impact: 0.6

Zoom shares tumble on earnings miss, soft profit guidance

Corporate EarningsCorporate Guidance & OutlookArtificial IntelligenceTechnology & InnovationAnalyst InsightsCompany FundamentalsProduct LaunchesInvestor Sentiment & Positioning
Zoom shares tumble on earnings miss, soft profit guidance

Zoom reported Q4 fiscal 2026 non‑GAAP EPS of $1.44, missing the $1.49 consensus by $0.05, while revenue of ~$1.247–1.25 billion modestly beat expectations and rose 5.3% year‑over‑year; enterprise revenue was $757.3 million and customers with >$100k ARR rose 9.3%. Management guided Q1 FY27 non‑GAAP EPS $1.40–$1.42 (below the $1.45 consensus) and revenue $1.22–1.225 billion (roughly in line), and full‑year FY27 revenue $5.065–5.075 billion with non‑GAAP EPS $5.77–$5.81 (below the $6.07 Street estimate); GAAP EPS was bolstered by $532.3 million pre‑tax gains from an Anthropic stake. The mixed top‑line beat but bottom‑line miss and softer EPS guidance prompted investor caution and an initial >11% stock gap down despite positive analyst commentary on AI product traction.

Analysis

Market structure: Zoom’s print signals continued enterprise demand for AI-enabled collaboration but shows investor sensitivity to EPS misses and interest‑income noise. Winners include cloud/AI infrastructure providers (MSFT, GOOGL) and AI feature vendors benefiting from increased usage; losers are pure UCaaS/rev‑per‑user dependent players if enterprise upgrade cycles stall. Expect modest pricing power retention in large accounts (98% retention, +9% $100k customers) but slower net‑new seat growth keeps top‑line expansion in the low single digits over the next 4–8 quarters. Risk assessment: Tail risks include a revaluation of Anthropic-related gains (capital markets/valuation reset), larger than guided interest income headwinds, or macro-driven enterprise IT cuts; any of these could shave >10–20% from non‑GAAP EPS volatility. Near term (days–weeks) volatility will be driven by sentiment and IV; short term (1–3 quarters) risks center on execution of AI product monetization; long term (≥12 months) depends on FCF delivery ($1.7–1.74B guide) and sustained ARR acceleration. Trade implications: Tactical idiosyncratic long exposure is justified but size should be disciplined — the beat/miss and mixed guide create a 6–12 month asymmetric trade: limited downside if FCF meets guide, upside if AI monetization reaccelerates. Use relative trades (long ZM vs short pure UCaaS like RNG/TWLO) and structured options (6‑month call spreads) to capture upside while capping downside; avoid naked short in high‑IV post‑print window. Contrarian angles: The market is underweight the operating cash generation and 98% enterprise retention; consensus is over‑penalizing a $0.05 EPS miss and interest income drag rather than core margins (non‑GAAP op margin 39.3%). Mispricing can persist short term, but if Anthropic mark‑to‑market reverses or FCF misses by >5% versus guide, re‑rate risk is real — watch FCF < $1.65B or FY27 EPS below $5.60 as triggers to materially cut exposure.